Ausgabe 1/2012
Inhalt (36 Artikel)
Is knowledge translation adequate? A quality assurance study of staging investigations in early stage breast cancer patients
Dolly Han, Sophie Hogeveen, Miriam Sweet Goldstein, Ralph George, Christine Brezden-Masley, Jeffrey Hoch, Rashida Haq, Christine E. Simmons
Bloody nipple discharge is a predictor of breast cancer risk: a meta-analysis
Ling Chen, Wen-Bin Zhou, Yi Zhao, Xiao-An Liu, Qiang Ding, Xiao-Ming Zha, Shui Wang
Genomic profiling of mitochondrion-rich breast carcinoma: chromosomal changes may be relevant for mitochondria accumulation and tumour biology
Felipe C. Geyer, Dario de Biase, Maryou B. K. Lambros, Moira Ragazzi, Maria A. Lopez-Garcia, Rachael Natrajan, Alan Mackay, Ivana Kurelac, Giuseppe Gasparre, Alan Ashworth, Vincenzo Eusebi, Jorge S. Reis-Filho, Giovanni Tallini
Mutational characterization of individual breast tumors: TP53 and PI3K pathway genes are frequently and distinctively mutated in different subtypes
Sandrine Boyault, Youenn Drouet, Claudine Navarro, Thomas Bachelot, Christine Lasset, Isabelle Treilleux, Eric Tabone, Alain Puisieux, Qing Wang
Digital image analysis of membrane connectivity is a robust measure of HER2 immunostains
Anja Brügmann, Mikkel Eld, Giedrius Lelkaitis, Søren Nielsen, Michael Grunkin, Johan D. Hansen, Niels T. Foged, Mogens Vyberg
COX2 overexpression is a prognostic marker for Stage III breast cancer
Hee Sung Kim, Hyeong-Gon Moon, Wonshik Han, Cha Kyung Yom, Woo Ho Kim, Jun Ho Kim, Dong-Young Noh
Estrogen and insulin-like growth factor-I (IGF-I) independently down-regulate critical repressors of breast cancer growth
Angelo J. Casa, Adam S. Potter, Simeen Malik, ZaWaunyka Lazard, Isere Kuiatse, Hee-Tae Kim, Anna Tsimelzon, Chad J. Creighton, Susan G. Hilsenbeck, Powell H. Brown, Steffi Oesterreich, Adrian V. Lee
Prolonged mammosphere culture of MCF-7 cells induces an EMT and repression of the estrogen receptor by microRNAs
I. K. Guttilla, K. N. Phoenix, X. Hong, J. S. Tirnauer, K. P. Claffey, B. A. White
Prevalence of BRCA1/2 mutations in sporadic breast/ovarian cancer patients and identification of a novel de novo BRCA1 mutation in a patient diagnosed with late onset breast and ovarian cancer: implications for genetic testing
Kim De Leeneer, Ilse Coene, Brecht Crombez, Justine Simkens, Rudy Van den Broecke, Alain Bols, Barbara Stragier, Ilse Vanhoutte, Anne De Paepe, Bruce Poppe, Kathleen Claes
Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis
Sivapriya Ramamoorthy, Rozina Tufail, Jimmy El Hokayem, Mercy Jorda, Wei Zhao, Zizi Reis, Zafar Nawaz
ErbB1/2 tyrosine kinase inhibitor mediates oxidative stress-induced apoptosis in inflammatory breast cancer cells
Katherine M. Aird, Jennifer L. Allensworth, Ines Batinic-Haberle, H. Kim Lyerly, Mark W. Dewhirst, Gayathri R. Devi
The influence of removal of primary tumor on incidence and phenotype of circulating tumor cells in primary breast cancer
Malgorzata Banys, Natalia Krawczyk, Sven Becker, Jolanta Jakubowska, Annette Staebler, Diethelm Wallwiener, Tanja Fehm, Ralf Rothmund
Insulin-like growth factor receptor (IGF-1R) in breast cancer subtypes
Rinat Yerushalmi, Karen A. Gelmon, Samuel Leung, Dongxia Gao, Maggie Cheang, Michael Pollak, Gulisa Turashvili, Blakes C. Gilks, Hagen Kennecke
Keratin 15, transcobalamin I and homeobox gene Hox-B13 expression in breast phyllodes tumors: novel markers in biological classification
Luke Yong-Zheng Chong, Poh Yian Cheok, Wai-Jin Tan, Aye Aye Thike, George Allen, Mei Kim Ang, Aik Seng Ooi, Patrick Tan, Bin Tean Teh, Puay Hoon Tan
Mesenchymal stem cells from primary breast cancer tissue promote cancer proliferation and enhance mammosphere formation partially via EGF/EGFR/Akt pathway
Xin-long Yan, Chun-jiang Fu, Lin Chen, Jin-hua Qin, Quan Zeng, Hong-feng Yuan, Xue Nan, Hai-xu Chen, Jun-nian Zhou, Yan-li Lin, Xiao-mei Zhang, Cheng-ze Yu, Wen Yue, Xue-tao Pei
Detection of aberrant promoter methylation of GSTP1, RASSF1A, and RARβ2 in serum DNA of patients with breast cancer by a newly established one-step methylation-specific PCR assay
Noriaki Yamamoto, Takahiro Nakayama, Masahiro Kajita, Tomohiro Miyake, Takashi Iwamoto, Seung Jin Kim, Ayako Sakai, Hideki Ishihara, Yasuhiro Tamaki, Shinzaburo Noguchi
Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profiles
Abena S. Agyeman, Raghothama Chaerkady, Patrick G. Shaw, Nancy E. Davidson, Kala Visvanathan, Akhilesh Pandey, Thomas W. Kensler
Prognostic value of acquired uniparental disomy (aUPD) in primary breast cancer
Musaffe Tuna, Marcel Smid, John W. M. Martens, John A. Foekens
Twenty-five year results of the national cancer institute randomized breast conservation trial
Nicole L. Simone, Tu Dan, Joanna Shih, Sharon L. Smith, Linda Sciuto, Elena Lita, Marc E. Lippman, Eli Glatstein, Sandra M. Swain, David N. Danforth, Kevin Camphausen
Impact of a telephone-based physical activity intervention upon exercise behaviors and fitness in cancer survivors enrolled in a cooperative group setting
Jennifer A. Ligibel, Jeffrey Meyerhardt, John P. Pierce, Julie Najita, Laura Shockro, Nancy Campbell, Vicky A. Newman, Leslie Barbier, Eileen Hacker, Marie Wood, James Marshall, Electra Paskett, Charles Shapiro
Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II–IIIc breast cancer
A. J. Montero, C. M. Diaz-Montero, Y. E. Deutsch, J. Hurley, L. G. Koniaris, T. Rumboldt, S. Yasir, M. Jorda, E. Garret-Mayer, E. Avisar, J. Slingerland, O. Silva, C. Welsh, K. Schuhwerk, P. Seo, M. D. Pegram, S. Glück
TIMP-1 in combination with HER2 and TOP2A for prediction of benefit from adjuvant anthracyclines in high-risk breast cancer patients
Pernille Braemer Hertel, Dongsheng Tu, Bent Ejlertsen, Maj-Britt Jensen, Eva Balslev, Shan Jiang, Frances P. O’Malley, Kathleen I. Pritchard, Lois E. Shepherd, Annette Bartels, Nils Brünner, Torsten O. Nielsen
Incremental increase in VEGFR1+ hematopoietic progenitor cells and VEGFR2+ endothelial progenitor cells predicts relapse and lack of tumor response in breast cancer patients
Sarika Jain, Maureen M. Ward, Jennifer O’Loughlin, Marissa Boeck, Naomi Wiener, Ellen Chuang, Tessa Cigler, Anne Moore, Diana Donovan, Christina Lam, Marta V. Cobham, Sarah Schneider, Paul Christos, Rebecca N. Baergen, Alexander Swistel, Maureen E. Lane, Vivek Mittal, Shahin Rafii, Linda T. Vahdat
Folate intake and breast cancer mortality in a cohort of Swedish women
Holly R. Harris, Leif Bergkvist, Alicja Wolk
Polymorphisms in cycloxygenase-2 gene and breast cancer prognosis: association between PTGS2 haplotypes and histopathological features
Juliana S. Festa-Vasconcellos, Diogo N. Piranda, Laura M. Amaral, Vanessa Indio-do-Brasil, Sérgio Koifman, Rosane Vianna-Jorge
The association between mammographic density measures and aspirin or other NSAID use
Jennifer Stone, Lisa Willenberg, Carmel Apicella, Susan Treloar, John Hopper
Epstein–Barr virus is seldom found in mammary epithelium of breast cancer tissue using in situ molecular methods
Kimberly Baltzell, Gertrude C. Buehring, Savitri Krishnamurthy, Henry Kuerer, Hua Min Shen, Jennette D. Sison
Breast tenderness and breast cancer risk in the estrogen plus progestin and estrogen-alone women’s health initiative clinical trials
Carolyn J. Crandall, Aaron K. Aragaki, Jane A. Cauley, Anne McTiernan, JoAnn E. Manson, Garnet Anderson, Rowan T. Chlebowski
Women’s features and inter-/intra-rater agreement on mammographic density assessment in full-field digital mammograms (DDM-SPAIN)
Beatriz Pérez-Gómez, Franciso Ruiz, Inmaculada Martínez, María Casals, Josefa Miranda, Carmen Sánchez-Contador, Carmen Vidal, Rafael Llobet, Marina Pollán, Dolores Salas
Hormone therapy use and mammographic density in postmenopausal Norwegian women
Elisabeth Couto, Samera Azeem Qureshi, Solveig Hofvind, Marit Hilsen, Hildegunn Aase, Per Skaane, Lars Vatten, Giske Ursin
Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancer
Ana Blanco, Miguel de la Hoya, Judith Balmaña, Teresa Ramón y Cajal, Alex Teulé, María-Dolores Miramar, Eva Esteban, Mar Infante, Javier Benítez, Asunción Torres, María-Isabel Tejada, Joan Brunet, Begoña Graña, Milagros Balbín, Pedro Pérez-Segura, Ana Osorio, Eladio A. Velasco, Isabel Chirivella, María-Teresa Calvo, Lidia Feliubadaló, Adriana Lasa, Orland Díez, Angel Carracedo, Trinidad Caldés, Ana Vega
Prognostic role of CA15.3 in 7942 patients with operable breast cancer
M. T. Sandri, M. Salvatici, E. Botteri, R. Passerini, L. Zorzino, N. Rotmensz, A. Luini, C. Mauro, V. Bagnardi, M. C. Cassatella, F. Bottari, C. Casadio, M. Colleoni
Correlation of white female breast cancer incidence trends with nitrogen dioxide emission levels and motor vehicle density patterns
Fan Chen, William F. Bina
Somatic mutations in the BRCA1 gene in Chinese women with sporadic breast cancer
Min Zhang, Ye Xu, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Tie Fan, Benyao Lin, Yuntao Xie
Lack of association between common single nucleotide polymorphisms in the TERT-CLPTM1L locus and breast cancer in women of African ancestry
Yonglan Zheng, Temidayo O. Ogundiran, Clement Adebamowo, Katherine L. Nathanson, Susan M. Domchek, Timothy R. Rebbeck, Michael S. Simon, Esther M. John, Anselm Hennis, Barbara Nemesure, Suh-Yuh Wu, Maria Cristina Leske, Stefan Ambs, Qun Niu, Jing Zhang, Nancy J. Cox, Olufunmilayo I. Olopade, Dezheng Huo
Evaluating breast cancer risk projections for Hispanic women
Matthew P. Banegas, Mitchell H. Gail, Andrea LaCroix, Beti Thompson, Maria Elena Martinez, Jean Wactawski-Wende, Esther M. John, F. Allan Hubbell, Shagufta Yasmeen, Hormuzd A. Katki